| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/28/2006 | WO2006099685A1 Method for the prophylaxis or treatment of carcinomas |
| 09/28/2006 | WO2006099684A1 Copper complexes |
| 09/28/2006 | WO2006099681A1 Isoflavonoid dimers |
| 09/28/2006 | WO2006099677A1 Metal complexes |
| 09/28/2006 | WO2006099667A1 Prophylactic and therapeutic agents and uses therefor |
| 09/28/2006 | WO2006099651A1 Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups |
| 09/28/2006 | WO2006086103A3 Synthesis of inhibitors of p90rsk |
| 09/28/2006 | WO2006085217A3 Solid adsorbates of hydrophobic drugs |
| 09/28/2006 | WO2006079719A3 Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/28/2006 | WO2006078876A9 Compositions and methods relating to mitochondrial hyperpolarization in neurological disease |
| 09/28/2006 | WO2006077426A3 4- (2, 6-DICHLOROBENZOYLAMINO) -lH-PYRAZOLE-3 -CARBOXYLIC ACID PIPERIDIN- 4 -YLAMID ACID ADDITION SALTS AS KINASE INHIBITORS |
| 09/28/2006 | WO2006076246A3 Phenylglycinamide derivatives useful as anticoagulants |
| 09/28/2006 | WO2006075023A3 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 09/28/2006 | WO2006074445A3 Novel heteropyrrole analogs acting on cannabiniod receptors |
| 09/28/2006 | WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 09/28/2006 | WO2006074227A3 HIGHLY ANTIPROLIFERATIVE, LOW-CALCEMIC, ANALOGS OF THE HORMONE 1α, 25-DIHYDROXYVITAMIN D3 WITH CARBONYL SIDE CHAINS |
| 09/28/2006 | WO2006073592A3 SALTS OF N-[2-({3R)-1-[trans-4-HYDROXY-4-(6-METHOXYPYRIDIN-3-YL)-CYCLOHEXYL]PYRROLIDINE-3-YL}AMINO)-2-OXOETHYL]-3-(TRIFLUOROMETHYL)BENZAMIDE |
| 09/28/2006 | WO2006072608A3 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 09/28/2006 | WO2006069998A3 Glycopyrrolate in cosmetic preparations |
| 09/28/2006 | WO2006067867A8 Cell adhesion factor expression inhibitor |
| 09/28/2006 | WO2006067330B1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 09/28/2006 | WO2006066747A8 4-aminopiperidine derivatives |
| 09/28/2006 | WO2006065942A3 Thiazolium compounds and uses thereof |
| 09/28/2006 | WO2006062932A3 Treatment with omega-3 fatty acids and ppar agonist and/or antagonist and a combination product thereof |
| 09/28/2006 | WO2006060336A3 Endothelin-2 and retinal damage |
| 09/28/2006 | WO2006058236A3 Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease |
| 09/28/2006 | WO2006057998A8 Binary antitumor compositions platinum (iv) derivatives |
| 09/28/2006 | WO2006055725A3 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 09/28/2006 | WO2006054175A3 Stable dosage forms of acid labile drug |
| 09/28/2006 | WO2006053342A3 Integrin antagonists useful as anticancer agents |
| 09/28/2006 | WO2006052962A3 Bicyclic triazole a4 integrin inhibitors |
| 09/28/2006 | WO2006052850A3 Motexafin lutetium phototherapy with low fluences for treating vascular inflammation |
| 09/28/2006 | WO2006051314A8 Guanidine derivatives as inhibitors of ddah |
| 09/28/2006 | WO2006050451A3 Methods and compositions to treat motor neuron disease |
| 09/28/2006 | WO2006047842A3 Modified nucleosides for rna interference |
| 09/28/2006 | WO2006047503A3 Inhibitors of c-fms kinase |
| 09/28/2006 | WO2006047476A3 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 09/28/2006 | WO2006044975A3 Compositions and their use as anti-tumor agents |
| 09/28/2006 | WO2006037047A3 The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
| 09/28/2006 | WO2006036768A3 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 09/28/2006 | WO2006028810A3 Method of wound healing using a2b adenosine receptor antagonists |
| 09/28/2006 | WO2006026083A3 Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids |
| 09/28/2006 | WO2006025979A3 Modulators of nuclear receptors |
| 09/28/2006 | WO2006023654A3 Awat-related methods and articles |
| 09/28/2006 | WO2006015861A3 Drop preparations comprising dimetindene |
| 09/28/2006 | WO2006015232B1 Use of methyl pyruvate for the purpose of increasing muscle energy production |
| 09/28/2006 | WO2006014348A3 Spray composition having a deposition control agent |
| 09/28/2006 | WO2006012958A3 Combination comprising a bcrp inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 09/28/2006 | WO2006012577A3 Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake |
| 09/28/2006 | WO2006005057A3 Muscarinic acetylcholine receptor antagonists |
| 09/28/2006 | WO2006004795A3 Angiogenesis inhibitors |
| 09/28/2006 | WO2006003492A3 Compositions and methods for treating pathological infections |
| 09/28/2006 | WO2005118567A3 Magnesium complexes of s-omeprazole |
| 09/28/2006 | WO2005117880A3 Methods for treating anxiety disorders and related article of manufacture |
| 09/28/2006 | WO2005117873A3 Compositions containing opioid antagonists |
| 09/28/2006 | WO2005117591A3 Novel pharmaceutical formulation containing a biguanide and an angiotensin antagonist |
| 09/28/2006 | WO2005108573A8 METHOD TO INDUCE RNAi IN PROKARYOTIC ORGANISMS |
| 09/28/2006 | WO2005107714A3 Method of forming microparticles that include a bisphosphonate and a polymer |
| 09/28/2006 | WO2005094234A3 Dietary supplement for treating digestive system disorders |
| 09/28/2006 | WO2005082459A3 Method of decreasing blood cells |
| 09/28/2006 | WO2005080384A3 Benzimidazole derivative and use as aii receptor antagonist |
| 09/28/2006 | WO2005072292A3 Methods for enhancing radiation therapy |
| 09/28/2006 | WO2005070393A3 Directly compressible pharmaceutical composition of the rapamycin ester cci-779 |
| 09/28/2006 | WO2005065718A8 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 09/28/2006 | WO2005065654A3 Rosiglitazone formulations |
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/28/2006 | WO2005060341A3 Tellurium derivatives for prevention and treatment of neurodegenerative processes |
| 09/28/2006 | WO2005046659A8 Migraine treatments including isovaleramide compounds and serotonin agonists |
| 09/28/2006 | WO2005040157A3 Novel mch receptor antagonists |
| 09/28/2006 | WO2005028489A3 Novel adenosine a3 receptor agonists |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | WO2004069146A3 L-dopa amide derivatives and uses thereof |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/28/2006 | US20060217563 tetraheterocyclicspiro compound containing pyrazole ring; for treating a variety of autoimmune and inflammatory diseases |
| 09/28/2006 | US20060217562 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 09/28/2006 | US20060217561 Synthesis of substituted thiazoline carboxylic acids |
| 09/28/2006 | US20060217557 Polymorphic form XVI of fexofenadine hydrochloride |
| 09/28/2006 | US20060217556 Benzoxepino-11-piperidylidene compounds and process for production thereof |
| 09/28/2006 | US20060217546 3-Deoxypentopyranosyl nucleic acid, its production and its use |
| 09/28/2006 | US20060217534 Bis (amino acid) molecular scaffolds |
| 09/28/2006 | US20060217446 Method for preventing and/or treating trichomonas vaginitis |
| 09/28/2006 | US20060217445 Natural astaxanthin extract reduces dna oxidation |
| 09/28/2006 | US20060217444 Tramadol for the treatment of functional gastrointestinal disorders |
| 09/28/2006 | US20060217443 Method for preventing and/or treating vaginal and vulval infections |
| 09/28/2006 | US20060217442 Preventive or ameliorating agent for liver disease involving hepatopathy |
| 09/28/2006 | US20060217441 foods containing triglycerides where polyunsaturated fatty acid is bonded to 2-position of triglyceride |
| 09/28/2006 | US20060217440 Porcess for production of 2-cyano-3-hydroxy-n-(4-trifluoromethylphenyl)hept-2-en-6-ynamide and process for production of polymorphs thereof |
| 09/28/2006 | US20060217439 Compounds with stabilized S-nitrosyl group and a free alcohol or a free thiol; nitric oxide (NO) releasing; bacteristats; reacting a polythiol or a thioalcohol with a nitrosylating agent (S-Nitrosyl-N-acetyl-D,L-penicillamine (SNAP) and and tert-butylnitrite); |
| 09/28/2006 | US20060217438 Treatment for herpes simplex virus and other infectious diseases |
| 09/28/2006 | US20060217437 TGF-beta modulators and methods for using the same |
| 09/28/2006 | US20060217436 Process for the preparation of docetaxel trihydrate |
| 09/28/2006 | US20060217435 5-bromo-thiophene-2-carboxylic acid-{1-[3-methyl-4-(3-oxo-piperazine-1-carbonyl)-phenyl]-5-oxo-pyrrolidin-3-yl}-amide; factor Xa-inhibiting activity; thrombosis |
| 09/28/2006 | US20060217434 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | US20060217432 3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 09/28/2006 | US20060217431 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor |
| 09/28/2006 | US20060217430 Use of inhibitors such as 2-Chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-methoxy-ethyl)-5-oxo-4,5-dihydro-[1,2,4]triazol-1-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders, rheumatoid arthritis |
| 09/28/2006 | US20060217429 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/28/2006 | US20060217428 Salt and polymorphs of a DPPIV inhibitor |
| 09/28/2006 | US20060217427 Cytoskeletal active compounds, compositions and use |